Abstract
Background
To enumerate possible intracranial vascular sequelae of sickle-cell disease, to identify risk factors and outline management strategies.
Method
Retrospective review of a single unit experience managing vascular intracranial complications of sickle-cell disease from 1995 until 2005. Information such as homozygosity/heterozygosity, duration of disease, disease control as indicated by haematology follow-up, concurrent sickle-cell disease (SCD)-related health problems and neurosurgical management was recorded. The pattern of vascular disease was analysed to reveal possible contributory/risk factors towards development of vascular intracranial complications.
Subjects
All patients presenting with vascular intracranial complications of sickle-cell disease from 1995 to 2005 were evaluated.
Outcome measures
Classification of vascular intracranial complications into one or more of the following categories: aneurysmal subarachnoid haemorrhage, non-aneurysmal subarachnoid/intraventricular haemorrhage and vasculitis.
Findings
There were ten patients in the study. All symptomatic vascular intracranial complications of SCD requiring neurosurgical intervention were homozygous for SCD. Aneurysms were likely to be multiple. Ruptured aneursyms in SCD were small (average 4 mm). There was a propensity for aneurysms to occur in the posterior circulation, in particular the posterior cerebral artery was frequently involved. Patients with aneurysms and Moyamoya-type vasculitis were likely to have occlusive disease of the internal carotid arteries.
Conclusions
The vascular intracranial complications of sickle-cell disease have an aggressive natural history. Tight control of SCD may reduce the possibility of complications. Complications that arise should be managed in the context of the disease entity rather than in isolation. Consideration should be given to bypass procedures, parent vessel ligations and revascularization techniques. Transcranial Doppler may be used to identify SCD patients with cerebrovascular occlusive disease, who may have increased risk of aneurysmal rupture.
Similar content being viewed by others
References
Overby C, Rothman AS (1985) Multiple intracranial aneurysm in sickle-cell patients. J Neurosurg 62:430–434
Pegelow CH (2001) Stroke in children with sickle-cell anaemia: aetiology and treatment. Paediatr Drugs 3:421–432
Dobson SR, Holden KR, Nietart PJ, Cure JK, Laver JH, Disco D, Abboud MR (2002) Moyamoya syndrome in childhood sickle-cell disease: a predictive factor for recurrent cerevbrovascular events. Blood 99:3144–3150
Anson JA, Koshy M, Ferguson L, Crowell RM (1991) Subarachnoid haemorrhage in sickle-cell disease. J Neurosurg 75:552–558
Oyesiku N, Barrow DL, Eckman JR, Tindall SC, Colohan MD (1995) Intracranial aneurysms in sickle-cell anaemia: clinical features and pathogenesis. J Neurosurg 75:356–363
Preul MC, Fernando C, Norman J, Gerard M (1998) Intracranial aneuryms and sickle-cell anaemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery 42:971–977
Batjer HH, Adamson TE, Bowman GW (1991) Sickle-cell disease and aneurysmal subarachnoid haemorrhage. Surg Neurol 36:145–149
Fryer RH, Anderson RC, Chiribega CA (2003) Sickle-cell anaemia with Moyamoya disease: outcome after the EDAS procedure. Paediatr Neurol 29:124–130
Ross CS, Hennessy JM (2007) Subarachnoid haemorrhage in a young child with sickle-cell disease: is transcranial Doppler helpful? Paediatrics 119:1249–1250
Fryer RH, Anderson RC, Chiribega CA (2003) Sickle-cell anaemia with moyamoya disease: outcome after the EDAS procedure. Paediatric Neurology 29:124–130
Close RA, Bucheit WA (1977) The management of ruptured intracranial aneurysm in sickle-cell anaemia:- Case Report. J Neurosurg 47:761–765
McConachie NS, Jaspan T (1999) Complications of sickle-cell disease: intracranial aneurysm and their treatment. Clin Radiol 53:388–389
Mehta SH, Adams RJ (2006) Treatment and prevention of stroke in children with sickle-cell disease. Curr Treatm Opt Neurol 8:503–512
Vicari P, Choairy ANC, Siufi GC et al (2004) Embolisation of intracranial aneurysms and sickle-cell disease. Am J Haematol 76(1):83–84
Hankinson TC, Bohman LE, Heyer G (2008) Surgical treatment of moyamoya syndrome in patients with sickle-cell anaemia: outcome following EDAS. J Neurosurg 1:211–216
Vernet O, Mentes JL, O’Gorman AM (1996) Encephaloduroarterio-syngiosis in a child with sickle-cell anaemia and moyamoya disease. Paediatr Neurol 14:226–230
Fukui M (1997) Current state of study on moyamoya disease in Japan. Surg Neurol 19:66–70
Conflicts of interests
None
Author information
Authors and Affiliations
Corresponding author
Additional information
Comments
Naturally, we only very rarely see patients with SCD in general in Finland where the prevalence of aneurysms in is the same as elsewhere but the incidence of SAH is twice higher together with Japan for unknown probably genetic reasons [1]. SCD patients are known to have intracranial vascular complications, in the present study in 2.7%. SCD patients with SAH were as the authors note, younger with smaller aneurysms that were more often multiple and in the posterior circulation than in the normal SAH population. An adjunct to the mechanisms postulated for the development of aneurysms in SCD patients, one could also add the role of inflammation [2, 3] after the arterial walls have been weakened by endothelial damage and increased hemodynamic stress. To screen or follow-up homozygous SCD patients’ cerebral vessels, preferably MRA could be performed and when needed CTA or DSA to keep the adverse effects of radiation after repeated scans minimal.
1. Bilguvar K, Yasuno K, Niemelä M, Ruigrok YM, Jääskeläinen JE, van Duijn CM, van den Berg LH, Mane S, Mason CE, Choi M, Gaal E, Bayri Y, Kolb L, Arlier Z, Ravuri S, Fraunberg M, Tajima A, Laakso A, Hata A, Kasuya H, Breteler MMB, Wijmenga C, State MW, Rinkel GJE, Hernesniemi J, Inoue I, Palotie A, Lifton RP, Günel M. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 40(12):1472-1477, 2008
2. Tulamo R, Frösen J, Junnikkala S, Paetau A, Kangasniemi M, Niemelä M, Jääskeläinen J, Jokitalo E, Karatas A, Hernesniemi J, Meri S. Complement activation associates with saccular aneurysm wall degeneration and rupture. Neurosurgery 59(5):1069-1076, 2006
3. Tulamo R, Frösen J, Junnikkala S, Paetau A, Kangasniemi M, Pelaez J, Hernesniemi J, Niemelä M, Meri S. Complement system becomes activated by the classical pathway in intracranial aneurysm walls. Lab Invest 90(2):168-179, 2010
Mika Niemelä
Juha Hernesniemi
Helsinki, Finland
Rights and permissions
About this article
Cite this article
Liaquat, I., Murphy, M., Bassi, S. et al. Paediatric and adult vascular intracranial complications of sickle-cell disease. Acta Neurochir 152, 1175–1179 (2010). https://doi.org/10.1007/s00701-010-0628-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-010-0628-3